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Abstract
HLA-DRB1 is the most polymorphic MHC (major histocompatibility complex) class II gene in human, and plays a crucial role
in the development and function of the immune system. Extensive polymorphisms exist in the promoter and 39-UTR of HLA-
DRB1, especially a LTR (Long terminal repeat) element in the promoter, which may be involved in the expression regulation.
However, it remains unknown how the polymorphisms in the whole promoter region and 39-UTR to regulate the gene
expression. In this study, we investigated the extensive polymorphisms in the HLA-DRB1 promoter and 39-UTR, and how
these polymorphisms affect the gene expression in both independent and jointly manners. It was observed that most of the
haplotypes in the DRB1 promoter and 39-UTR were clustered into 4 conserved lineages (H1, H2, H3 and H4), and showed
high linkage disequilibrium. Compared with H1 and H2 lineage, a LTR element in the promoter of H3 and H4 lineage
significantly suppressed the promoter activity, whereas the activity of the linked 39-UTR increased, leading to no apparent
difference in the final expression product between H1/H2 and H3/H4 lineage. Nevertheless, compared with the plasmid
with a promoter and 39-UTR from the same lineage, the recombinant plasmid with a promoter from H2 and a 39-UTR from
H3 showed about double fold increased luciferase activity, Conversely, the recombinant plasmid with a promoter from H3
and a 39-UTR from H2 resulted in about 2-fold decreased luciferase activity. These results indicate that the promoter and 39-
UTR of HLA-DRB1 may antagonistically regulate the gene expression, which may be subjected to stabilizing selection. These
findings may provide a novel insight into the mechanisms of the diseases associated with HLA-DRB1 genes.
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Introduction
Major histocompatibility complex (MHC) plays a crucial role in
the regulation of immune response. Since the landmark discovery
of MHC restricted T-cell recognition by Zinkernagel and Doherty
[1], Numerous studies have concentrated on how T-cells are
trained to recognize self-peptide:self-MHC complex (pMHC) by
positive and negative selection in thymus [2–4]. Both the avidity of
the T-cell receptor (TCR) to the pMHC and the density of pMHC
on the thymic cortical epithelial cell contributes to the conse-
quence of the positive and negative selection for T-cells [5].
Although previous studies have revealed that the concentration of
self-peptide ligands and their affinity to TCR may influence the
outcome of positive selection and negative selection [6–7], but very
limited studies were reported on how the amount of pMHC affects
the consequences of positive or negative selection for thymocytes.
Patients lacking MHC class II, known as the bare lymphocyte
syndrome (BLS), were subjected to severe immune deficiency, and
they were devoid of peripheral CD4+ T-cells [8]. Additionally, it
was shown that decreased expression of HLA-DR molecules in
thymoma may affect on CD4+ T-cell development [9]. Analysis
based on BLS patients suggested that abnormal MHC II
expression level may impair CD4+ T-cell development. Apart
from this, MHC-II molecules also play very important roles in the
native immune response. Deficiency of MHC-II attenuates the
Toll-like receptors (TLRs) triggered inflammation [10].
HLA-DR molecules are constitutively expressed on the cell
surface of B lymphocytes, thymic cortical epithelial cells, dendritic
cells (DCs), monocytes and other antigen presenting cells (APC),
with the function of presenting antigens T-cells [11–12]. DR
molecules function as the heterodimer consisted of DR alpha
(encoded byDRAlocus) andDRbetachains(encodedbyDRBloci,
including DRB1, DRB3, DRB4 and DRB5), HLA-DRA is
monomorphic, whereas HLA-DRB, especially DRB1, is highly
polymorphic [13–14]. Among the MHC II members, HLA-DR
plays the most crucial role in the human immune system since it
accounts for more than 90% of the HLA class II isotypes expressed
on antigen-presenting cells [14]. Because the HLA-DRB1 genes
located on different DR haplotypes are vastly diversified, and some
DR haplotypes also comprise another DRB encoding gene except
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formed in an individual depending on the DR haplotypes [15]. The
expression level of DRB alleles determines the amount of a variety
of functional DR heterodimers on the surface of APCs, which may
in turn influence the quantity and ratio of mature T-cells with
different specificity. In other words, the expression regulation of
HLA-DR molecules is very important for CD4+ T-cells selection
and activation during the adaptive immune response. Since the
expression level of HLA-DRB1 loci was demonstrated to be much
higher than that of other HLA-DRB coding loci (DRB3, DRB4 and
DRB5) [16–17], and HLA-DRB1 was also the most reported MHC
gene in association with different diseases [18–26]. The regulation
of HLA-DRB1 expression, the dominant locus which expresses
HLA-DR, must be under delicate control. Previous studies revealed
that the polymorphisms in the core promoter of HLA-DRB1 gene
caused a significant change of the promoter activity [17,27–31].
However, the mechanism underlying this effect is still unknown.
Polymorphisms in regulatory cis-elements may impact on the
phenotypic outcomes in a highly variable and unpredictable fashion
[32]. Many retro-elements, such as LINEs (long interspersed
nuclear elements), SINEs (short interspersed nuclear elements)
and LTRs (long terminal repeats), could play important roles in the
regulationof gene expression [33]. In the past decades, 39-UTR was
also demonstrated to contain important cis-elements for gene
expression regulation. It is very popular that distinct length of 39-
UTRs are produced by alternative polyadenylation (APA) in
different cell types and cell stages, regulating the final product of
gene expression [34]. To understand the evolution of the regulatory
region of HLA-DRB1 and assess the functional consequence of the
polymorphisms in these regions, we sequenced about 4.6 kb of
HLA-DRB1 promoter region including 59-UTR and 2.6 kb of 39
non-coding region (39-NCR) containing entire 39-UTR from 26
normal Han Chinese, and used the dual luciferase reporter gene
assay system to experimentally determine the effect of the
polymorphisms in HLA-DRB1 promoter and 39-UTR on gene
expression. This study first explored how the polymorphisms in the
promoter and 39-UTR of HLA-DRB1 to regulate the gene
expression.
Results
Most of the Haplotypes in HLA-DRB1 Promoter and
39-UTR were Grouped into Four Distinct Lineages
A total of 51 promoter sequences and 50 39-UTR sequences
were obtained, and the new sequences were submitted to
GenBank (http://www.nlm.nih.ncbi.org) and assigned a GenBank
accession number of FJ464430 to FJ464461. Phylogenetic analysis
showed that the sequences from both promoter and 39-UTR were
clustered apparently into 4 deep clades, which were designated as
H1, H2, H3 and H4 for promoter clades (Figure 1A), and UTH1,
UTH2, UTH3 and UTH4 for 39-UTR (Figure 1B), respectively.
One unique 39-UTR haplotype denoted as UTHx was derived
from HLA-DRB1*10:01:01 (Figure 1B). Linkage analysis between
promoters, exon2 and 39-UTRs revealed four tightly linked
lineages, namely H1-UTH1-exon2 (DR01, DR15 and DR16),
H2-UTH2-exon2 (DR03, DR08, DR11, DR12, DR13 and
DR14), H3-UTH3-exon2 (DR07 and DR09) and H4-UTH4-
exon2 (DR04) (Figure 2). The evolutionary relationship among all
haplotypes except for UTHx is very similar on the 39-UTR tree
and the 39-UTR downstream (39-UTR-DS) tree. The UTHx was
clustered with UTH2 lineage on the 39-UTR tree, but it is more
ancient on the 39-UTR-DS tree (Figure S1).
There are extreme differences among lineages but low diversity
within lineages in both promoter and 39-UTR. The frequency
spectrum analysis showed that the most moderate frequency alleles
exist in the DRB1 promoters (Figure S2) and the similar
distribution of a frequency spectrum is observed for 39-UTR
(data not shown). When we performed Tajima’s D test and Fu and
Li’s test by taking account for all lineages together or only one
lineage, a notable difference was observed (Table S1). When we
considered all lineages together, the nucleotide diversity (p) are
0.05053 and 0.07263 in the promoter region and 39-UTR,
respectively. In promoter region, Tajima’s D is 2.43186 (P,0.05 ).
Fu and Li’s D* test statistic is 2.09095 ( P,0.02) and Fu and Li’s
F* test statistic is 2.73971 (P,0.02). In 39-UTR, Tajima’s D is
2.3799 with a statistical significance P,0.05, Fu and Li’s D* and
F* is 1.8129 and 2.4305, respectively, and both with a statistical
Figure 1. Phylogenetic Tree Constructed with Various Parts of HLA-DRB1 Sequence. The taxon names that designated with H plus
numbers represent haplotypes from the promoter of DRB1 gene, and UTH plus numbers represent haplotypes from 39-UTR of DRB1 gene. The 1
st
number denotes the lineage which comprises all the sequences clustered on the same clade, and the numbers after the dot represent sublineages
and haplotypes, respectively. UTHx signifies the haplotype that is distinct from the others. Rhesus, part.DRB1 and marmoset indicates that the
corresponding sequence come from DRB1 gene of rhesus, chimpanzee and marmoset, respectively. All bootstrap values are shown on the nodes. A:
Phylogenetic tree was constructed with the 59-proximal promoter sequences. B: 39-UTR tree. C: Tree was constructed with exon2 sequences.
doi:10.1371/journal.pone.0025794.g001
HLA-DRB1 May Be Antagonistically Regulated
PLoS ONE | www.plosone.org 2 October 2011 | Volume 6 | Issue 10 | e25794significance (P,0.02; Table S1). The above results suggested that
the promoter and 39-UTR may have been subjected to balancing
selection. However, when we only selected the sequences grouping
in certain lineage or sub-lineage for analysis, low nucleotide
diversity was observed. For H3 lineage, the nucleotide diversity (p)
is 0.00083. Tajima’s D is 22.37453 (P,0.001 ). Fu and Li’s D*
test statistic is 23.26961 ( P,0.02) and Fu and Li’s F* test statistic
is 23.47765 (P,0.02). Tajima’s D, Fu and Li’s D* and F* test for
UTH1 are 21.84699, 22.50331 and 22.65713, respectively
(P,0.05) (Table S1). These results indicated that the polymor-
phism patterns within H3 and UTH1 lineage may have been
shaped by purifying or positive selection. The nucleotide diversity
between H12 (H1 and H2) and H34 (H3 and H4) in the 39-UTR
region is significantly higher than that in the promoter region.
However, the nucleotide diversity between H1 and H2, or H3 and
H4, in the 39-UTR region is slightly lower than that in the
promoter region (Figure 3). The above indicated that the 39-UTR
diverged faster between H12 and H34 than the promoter,
suggesting the 39-UTR was subjected to strong positive selection
after the separation of the DRB1 lineage of H12 and H34.
At least one SNP was observed in each of the cis-elements such
as TATA box, CAAT box, Y box, X box and W box (Figure S3).
We compared the SNP density in these cis-elements, their flanking
sequences from 21t o2200 bp, as well as 59-UTR among 4
DRB1 promoter lineages. SNP density is 72.5 SNPs/kb in the
regulatory boxes, 110.0 SNPs/ kb in flanking sequences and 45.0
SNPs/ kb in 59-UTR, respectively. The SNP density in flanking
sequences is higher than that in the regulatory boxes and 59-UTR,
suggesting the regulatory boxes and 59-UTR were subjected to
purifying selection.
The Promoter Activity of HLA-DRB1 Decreased in the
Absence of Its Linked 59-UTR
Dual luciferase reporter system was used to analyze the
expression activity of different promoter constructs. Whereas no
significant variation in luciferase expression level was observed
when the reporter gene was placed under the control of different
promoters together with the same 59-UTR from H2 lineage
(Figure 4A). We found a remarkable effect of different 59-UTRs on
the luciferase level. The expression of luciferase (P1-59U1, P1-
59U2, P1-59U3 and P1-59U4) driven by the same promoter
sequence derived from H1 lineage and different 59-UTRs obtained
from H1, H2, H3 and H4 lineages dropped increasingly, and
statistic significant differences were found between P1-59U1 and
P1-59U4, and between P1-59U2 and P1-59U4 (P,0.05), suggesting
the polymorphisms in the 59-UTR could affect the promoter
activity (Figure 4B). We also investigated the influence of the
DRB1 promoter with or without 59-UTR on the expression levels.
Analysis for the four paired corresponding promoter constructs
showed that the DRB1 promoter with its linked 59-UTR had
much higher transcription activity than that without 59-UTR in
Raji cells (Figure 4C). However, no significant difference was
observed among the constructs (P1-59U1H, P2-59U2H, P3-59U3H
Figure 2. Linkage Relationship between Promoters, Exon2 and 39-UTRs. Branch lengths for all trees are arbitrary, and Bootstrap values larger
than 50% are shown on the nodes. The three parts located on the same haplotype were connected with lines. The different color lines denote the
deeply separated lineages.
doi:10.1371/journal.pone.0025794.g002
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among the constructs (P1-W, P2-W, P3-W and P4-W) that include
only DRB1 promoter sequence without 59-UTR sequence
(Figure 4C). These results indicate that the polymorphisms in
the proximal promoter (21t o2535 bp) of HLA-DRB1 gene by
themselves do not impact on the promoter activity. However, the
polymorphisms in the 59-UTR may play an important role
through coordinately regulating the gene expression with those in
the promoter region.
A LTR Element Located at the Distal Promoter of H3 and
H4 Lineage Led to the Repression of Promoter Activity
The insertion of repetitive elements into the gene promoter
region usually affects the promoter activity. In order to explore the
potential influence of the LTR element in the H3 and H4 lineages
on activity of their promoters, we created constructs by cloning the
long promoter region (from +66 bp to 23200 bp) from each
DRB1 lineage into pGL3.0 basic vector, and simultaneously
constructed several recombinants by inserting the LTR into the
promoter sequence from H2 lineage. Compared with the
constructs of H3AIC (from H3 lineage) and H4AIC (from H4
lineage) which comprise a LTR element, the long promoter
constructs H1AC (from H1 lineage) and H2AC (from H2 lineage)
which contain no LTR element showed significantly increased
expression activity (P,0.01) (Figure 5). Furthermore, the expres-
sion activity of a construct (H2AIC) by inserting a LTR element
derived from H3 lineage greatly decreased (P,0.001) (Figure 5).
The above results suggest the insertion of LTR element
significantly impact on the promoter activity. However, deletion
of the LTR element in a construct H3AC could not apparently
increase the promoter activity, and yet the transcription activity of
a construct (IH3C) that excluding the upstream part of the LTR
was significantly decreased (P,0.05) (Figure 5). Another construct
IH2C was recombined with the proximal promoter from H2
lineage and a LTR element, unexpectedly, whose transcriptional
activity was not decreased compared with that of H2AC (Figure 5).
These findings indicate that the influence of the LTR on promoter
activity was depended on the sequence environment, and may act
through altering the secondary or tertiary structures required for
the binding of promoter complex.
Polymorphisms in the 39-UTR of HLA-DRB1 Counteract
the Influence of that in Its Linked Promoter on Expression
In order to find out whether the polymorphisms in 39-UTR of
HLA-DRB1 are involved in the regulation of gene expression, the
luciferase activities with various 39-UTR constructs were deter-
mined in 293T and Raji cells. A significant higher luciferase
activity was observed for the 39-UTR from DRB1 lineages of
UTH3 and UTH4 than that from DRB1 lineages of UTH1,
UTH2 and UTHx (Figure 6A). Similar results were obtained
when different DRB1 39-UTR sequences from various lineages
were placed in the constructs containing the same HLA-DRB1
promoter and 59-UTR sequence originated from lineage H2,
(Figure 6B). The above results showed that the effect of the
polymorphisms in 39-UTR on the expression regulation is reverse
to that in the promoter from same lineages. That being the case,
then similar luciferase activity should be observed among the
constructs in which the luciferase gene was placed under the
control of both 39-UTR and LP from the same lineage. This point
was experimentally demonstrated in Raji cells (Figure 6C).
Moreover, apparently increased luciferase activity was observed
with the recombinant plasmid (H2AC-39U3) in which the
luciferase gene was placed under the control of 39-UTR from
H3 lineage and LP from H2 lineage, and opposite changes was
obtained for the recombinant plasmid H3AIC-39U2 in which the
luciferase gene was placed under the control of 39-UTR from H2
lineage and LP from H3 lineage (Figure 6C). These results indicate
that the changes in expression of the HLA-DRB1 gene caused by
the polymorphisms in promoters can be counteracted by that in
their linked 39-UTRs, it is strongly suggested that HLA-DRB1
gene have been subjected to stabilizing selection in the
evolutionary history.
Discussion
In previous studies, it was reported that polymorphisms in cis-
elements located in the core promoter of HLA-DRB1 genes led to
apparent expression difference [17,27–31]. However, in this study,
no significant difference in promoter activity was observed
between 4 distinct promoter lineages within a region of about
600 bp, though in which polymorphisms almost reside in every cis-
Figure 3. Comparison of Nucleotide Diversity between Different Lineages or lineage combinations in Various Regions. H12
represents a lineage combination with lineage 1 and lineage 2; H34 denotes a lineage combination with lineage 3 and lineage 4; H1234 indicates a
lineage combination with all lineages. A: The nucleotide diversity was calculated by averaging the polymorphic site within the compared lineages. B:
The average nucleotide diversity (per site per sequence) was computed.
doi:10.1371/journal.pone.0025794.g003
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polymorphism in 59-UTR only as they linked with the same
promoter sequence (Figure 4B). The above phenomenon suggest-
ed that the sequence out of the core promoter (from TIS to about
2300 bp) also contributes much to the promoter activity, and the
promoter activity of different HLA-DRB1 lineages may be affected
by the antagonistic action among polymorphisms in the whole
promoter region. Inhibition of the promoter activity by the LTR
element in upstream of 2950 indicated that it is hard to suppose
the promoter activity for different DRB1 lineage by investigating
its core promoter region.
It is very interesting that the impact of the polymorphisms in the
39-UTR on the gene expression is just reverse to that in the
promoter, suggesting antagonistic regulation between the promot-
er and 39-UTR of HLA-DRB1 gene. This regulatory mechanism
ensures the 4 distinct HLA-DRB1 lineages, although with different
promoter activity, may have a similar final expression product. So
we proposed that it may be very important to maintain an
identical expression level for two distinct HLA-DRB1 alleles in an
individual, and HLA-DRB1 gene was subjected to stabilizing
selection in the evolutionary history.
Stabilizing selection between the alleles from distinct DRB1
lineages suggested that the maintenance of equal expression of two
distinct DRB1 alleles in an individual must have a very important
biological significance. Although the expression of most genes in
primate and model organisms was demonstrated to be subjected to
stabilizing selection [35–38], yet it was poorly understood for the
evolutionary mechanism. In this study, we experimentally
demonstrated a typical mechanism for stabilizing selection, which
was dependent on the antagonistic coevolution between the
promoter and 39-UTR. However, what’s the biological signifi-
cance for maintaining the relatively stable expression among the
distinct DRB1 lineages? In previous studies, it was revealed that
the ratio variation of MHC II I-A
g7 gene product to I-A
k product
in mixed MHC mice determined the difference in autoproliferative
response, and the higher ratio would cause more autoreactive T-
cells to evade negative selection into the periphery and readily
elicit autoimmune response [39]. Inefficient presentation of Self-
peptide to T-cells in the thymus causes a part of T-cells evading
from the negative selection and entering into the periphery, which
is one of the hypothetic mechanisms for autoimmune disease
demonstrated experimentally [39–40]. Lessons from the bare
lymphocyte syndrome (BLS) told us that the quantity of MHC II
molecules play key roles in thymocytes selection [41]. HLA-DRB1
is the most extensively studied MHC II genes, which are
constitutively expressed in B lymphocytes, dendritic cells and
macrophage cells, and is induced to express in other cells [42].
Many previous studies concluded that the polymorphisms in the
cis-elements of HLA-DRB1 promoters could greatly affect the
promoter activity [17,27–28], which led to a puzzling question of
what would have happened if the various promoters lead to
differential expression of two distinct HLA-DRB1 alleles in an
individual. Not only does the positive selection need interaction
with the MHC-peptide complex (pMHC), but also does the
negative selection [7]. Therefore, the types of MHC and its
quantities on the cell surface could affect the selection results for
mature T-cells. Maintaining the appropriate ratio of gene products
of two heterozygous alleles may be critical for T-cells selection and
activation, which could interpret why the polymorphisms in the
DRB1 39-UTR is implicated in the expression regulation on the
opposite effect of the polymorphisms in the DRB1 promoter.
Therefore, balancing the mature T-cell types may be the
fundamental biological significance for the stabilizing selection
acting on the expression of HLA-DRB1 genes, which may provide
new insight for the research on why DRB1 genes were associated
with so many diseases.
The promoter regions of MHC II genes were subjected to
Balancing selection [43–44]. In this study, extreme diversity
among lineages observed in HLA-DRB1 regulatory region
suggested a balance selection. However, very limited polymor-
phism within a lineage could not be explained by balance
selection. Moreover, each promoter and 39-UTR lineage are
linked with many diversified exons, implicating that the regulatory
region and the exons of HLA-DRB1 gene were subjected to
different natural selection. The limited polymorphisms in the
Figure 4. Relative Luciferase Activity of Constructs with HLA-
DRB1 Derived Promoter and 59-UTR Sequences. A: luciferase
activity was tested for the plasmids into which the different DRB1
lineage derived promoter sequences with lineage 2 derived 59-UTR
were inserted. B: Luciferase activity was tested for the plasmids into
which the promoter sequences from DRB1 lineage 1 with different
lineage-derived 59-UTR were inserted. C: Luciferase activity was tested
for the plasmids into which the different DRB1 lineage-derived
promoter sequence with or without its 59-UTR were inserted. Firefly
luciferase activity of each sample was normalized by Renilla luciferase
activities. The P4-59U4 (A), P1-59U4 (B) and pGL3.0 control vectors (C)
were used as controls, and the normalized luciferase activities of
controls were set as relative activity 1. Therefore no error bars were
shown for the P4-59U4, P1-59U4 and pGL3.0 control vector. The relative
luciferase activity of the other samples was calculated by their
normalized luciferase activity to that of the normalized controls. Error
bars represent standard error of the mean estimated from three
separate experiments. *, P,0.05; ***, P,0.001, compared with the
control or comparison between two groups as indicated.
doi:10.1371/journal.pone.0025794.g004
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PLoS ONE | www.plosone.org 5 October 2011 | Volume 6 | Issue 10 | e25794Figure 5. Relative Luciferase Activity under the Control of DRB1 Promoters with or without a LTR Insert. The strategy for constructing
the promoter vectors is shown on the left and the relative luciferase activity of corresponding vectors is shown on the right. H1, H2, H4 and H4
represent the sequences derived from promoter lineage H1, H2, H3 and H4 of DRB1, and A, C denotes the distal promoter segment and proximal
promoter segment, respectively. ‘‘I’’ denotes the insert LTR actually located at H3 lineage about 950 bp upstream from the transcription start site.
Firefly luciferase activity of each sample was normalized by Renilla luciferase activity. The pGL3.0 control vector (A) and H1AC (B) is used as controls,
and the normalized luciferase activity of control was set as relative activity 1. Therefore no error bar was shown for pGL3.0 control vector and H1AC.
The relative luciferase activity of the other samples was calculated by their normalized luciferase activity to that of the normalized control. Error bars
represent standard error of the mean estimated from three replicate experiments. *, P,0.05, **, P,0.01; ***, P,0.001, comparison between two
groups as indicated.
doi:10.1371/journal.pone.0025794.g005
Figure 6. Luciferase Activity was Detected for the 39-UTR from Different HLA-DRB1 Lineage. A: Luciferase activity was detected in 293T
cells for the plasmids into which different DRB1 lineage-derived 39-UTRs were inserted downstream the reporter gene. B: Luciferase activity was
detected in Raji cells for the plasmids into which a same DRB1 promoter sequence and different DRB1 lineage derived 39-UTRs were simultaneously
cloned up and downstream of the reporter gene, respectively. C: Luciferase activity was detected in Raji cells for the plasmids into which the naturally
linked long promoter sequence and 39-UTR from DRB1 lineages were simultaneously cloned up and downstream of the reporter gene, respectively.
The construct of H2AC-39U3 represented the plamids that the promoter and 39-UTR of the reporter gene were derived from DRB1 lineage 2 and
lineage 3, respectively. But the construct of H3AIC-39U2 was just reverse to H2AC-39U3. Firefly luciferase activity of each sample was normalized by
Renilla luciferase activity. The pGL-59U1-30U1 (A), P2-39U1 (B) and H1AC-39U1 (C) is used as controls, and the normalized luciferase activity of control
was set as relative activity 1. Therefore no error bar was shown for pGL-59U1-30U1, P2-39U1 and H1AC-39U1. The relative luciferase activity of the other
samples was calculated by their normalized luciferase activity to that of the normalized control. Error bars represent standard error of the mean
estimated from three replicate experiments. * P,0.05, ** P,0.01 and *** P,0.001 are indicated as the comparative significancce between two
groups.
doi:10.1371/journal.pone.0025794.g006
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reduction of diversity by recombination. Nevertheless, no
recombination signal was observed between the lineages. It was
well accepted that the exon 2 of HLA-DRB1 gene have been
subjected to balancing selection in its evolutionary history [45].
The exon 2 of HLA-DRB1 gene encodes antigen recognition site
(ARS) and peptide binding site (PBS), so high diversity in this
region implies that it may present more extensive exogenous
antigens, and the populations could be protected against more
pathogens [46–47]. Moreover, it is beneficial for populations
maintaining the diversity in exon 2 of DRB1 by balanced selection
[48–49]. When plague was prevalent in certain periods, some
special alleles which could present the antigen in the most efficient
way would be selectively survived. And in this circumstance,
positive selection played a major role. Because of a microorganism
evolving very fast, the ARS and PBR were necessarily driven to
evolve faster than any other part of the gene [50]. As it was
proposed in previous works, the pathogens may be the main force
which drives and maintains the remarkable polymorphism in the
MHC [51–52]. Anyway, the polymorphic pattern in exon 2 of
DRB1 gene is the consequence of ongoing balanced selection and
infrequently positive selection. Since our results showed that the
corresponding promoter lineage and 39-UTR lineage were linked
tightly, and they cooperatively worked to keep the similar
expression among different DRB1 lineages, suggesting that most
mutation occurred in the two regions would be deleterious. The
fact that SNP density in cis-elements and 59-UTR is lower than in
their flanking regions also indicates that purifying selection have
acted on DRB1 upstream regulatory region. Therefore, the
complicated polymorphism pattern in the promoter and 39-UTR
of HLA-DRB1 must have been attributed to the hitch-hiking by
the exons which are subjected to balancing selection, positive
selection or other natural selection.
The nucleotide diversities between lineage 12 (lineage 1 and
lineage 2) and lineage 34 (lineage 3 and lineage 4) in the 39-UTR
region is much higher than that in the promoter region, suggesting
that the 39-UTR and the promoter were subjected to different
natural selection. The 39-UTR from lineage 3 and 4 might be
subjected to positive selection so as to evade the suppression to
counteract the inhibition of its promoter activity. UTHx belongs
to DRB1*10:01:01 which was recombined with the allele on the
DR52 haplotype in intron 1 and has the most recent common
ancestor with the alleles on DR51 and DR52 haplotype [53]. The
position of UTHx haplotype on the 39-UTR tree and 39-UTR-DS
tree suggested that the 39-UTR have been subjected to stronger
natural selection than the downstream sequence. Most part of the
above may be contributed by the selective pressure of maintaining
the stable expression of the different HLA-DRB1 gene.
In conclusion, the expression of HLA-DRB1 may be antago-
nistically regulated by its coordinately evolved promoter and 39-
UTR under stabilizing selection. The polymorphic pattern in the
DRB1 promoter and 39-UTR was shaped by multiple natural
selection, such as purifying selection, positive selection, stabilizing
selection, and hitch-hiking by the polymorphic sites in the exons.
The findings in this study implicated that balancing the expression
of two different MHC II alleles in an individual may be very
important, which provide a novel insight into the pathogenic
mechanism of MHC involving in many diseases.
Materials and Methods
Samples
Whole blood samples were collected from 26 Han Chinese
volunteers from the different provinces. A written informed
consent was obtained from each participant, and this study was
conducted with the approval of the Institute Research Medical
Ethics Committee of Sun Yat-Sen University. Genome DNA was
extracted with Blood DNA kit (D3392-02) purchased from
OMEGA Bio-tek, Inc., Guangzhou, China.
Primer design
We downloaded 3 HLA-DRB1 reference sequences which
located at different DR haplotypes, namely DR51 (DRB1*
15:01:01, GenBank accession no. NG_002432), DR52 (DRB1*
03:01:01, GenBank accession no. NG_002392), and DR53
(DRB1*04:01:01, GenBank accession no. NG_002433). Sequence
alignment was performed with ClustalX 1.81, and all primers were
designed with primer premier 5.0. The primer pairs and their
relative positions were shown in Figure S4. Also, the sequencing
primers were designed and most of which were lineage specific. All
the primers were synthesized by Invitrogen (Shanghai, China) and
the primer sequences were shown in Table S2.
Long fragment amplification and investigation of linkage
relationships
The amplification was performed in a 50 ml of reaction system
containing 5 mlo f1 0 6LA buffer, 0.25 mM of dNTP, 0.24 mMo f
each primer, 20 ng of genome DNA and 2.5 U of TakaRa LA Taq
polymerase in which pfu enzyme was supplemented according to
1:19. A total of 35 cycles run in the PCR after preheating at 92uC
for 3 minutes, and for each cycle with denaturing at 95uC for
15 seconds, annealing at x uC (the ‘‘x’’ denotes the annealing
temperature that varies according to different primer pairs) for
30 seconds and extension at 68uC for y (the ‘‘y’’ means the
extension time for amplifying different length of fragments)minutes,
then elongating at 68uC for 10 minutes. The PCR products were
cleaned with Gel extraction Kit (OMEGA Bio-tek, Inc., Guangz-
hou, China), then sequenced directly and finally cloned into T-easy
vector (Promega Corporation, Madison, WI).
To investigate linkage relationship among promoter, exon 2,
and 39-UTR, we designed 2 universal primer pairs (CF and EH)
to amplify the fragment containing promoter region and exon 2,
as well as the fragment containing 39-UTR and exon 2 (Figure
S4). Then the fragments were cloned into T-easy vector, and one
positive clone was sequenced from two ends with sequencing
primers T7 and SP6 for each segment. The end sequences were
aligned with the known promoter sequences, exon 2 sequences
and 39-UTR sequences, respectively. Genotyping for exon 2 of
HLA-DRB1 gene was according to the description of Kotsch
[54]. We could get the linkage relationship between promoter
regions and 39-UTRs easily through analyzing the overlapping
exon 2.
Sequencing
The allele specific PCR product was purified by gel extraction
with DNA Gel Extraction Kit (OMEGA bio-tek, Inc., Guangz-
hou, China) followed by sequencing with haplotype specific
primers (Table S2) on an ABI 3730 sequencer using BigDye
Terminator V3.0 cycle sequencing kit. The plasmid was extracted
with Plasmid Mini kit (OMEGA bio-tek, Inc., Guangzhou, China)
followed by sequencing. All different sequences were submitted to
NCBI and the GenBank accession numbers were given as
FJ464430 to FJ464461.
Construction of expression vectors
The promoter lineages H1, H2, H3 and H4 were defined
according to the clusters of the promoter sequences (Figure 1A).
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DRB1*15 and DRB1*16; H2 indicates the promoter sequences
from DRB1*03, DRB1*08, DRB1*10, DRB1*11, DRB1*12,
DRB1*13 and DRB1*14; H3 denotes the promoter sequences
from DRB1*09 and DRB1*07, and H4 indicates the promoter
sequences from DRB1*04. In order to compare the influence of
different promoter lineages of HLA-DRB1 and their 59-UTR on
the gene expression level, we constructed 3 kinds of vectors by
inserting DRB1 promoter derived fragments with or without 59-
UTR into pGL3.0 Basic vectors. The first kind of promoter
constructs is that the luciferase gene was placed under the control
of different promoters from distinct DRB1 lineages and fused with
the 59-UTR from lineages H2. We denominated these vectors as
P1-59U2, P2-59U2, P3-59U2 and P4-59U2 (P1-4 represent the
promoter derived from promoter lineages H1-4, and the ‘‘59U2’’
indicates a 59-UTR from promoter lineage H2). The fragment,
including the promoter and 59-UTR sequence, were amplified
from lineage H4 was cloned into pGL3.0 basic vector as a control
(P4-59U4) (Figure S5A). The second kind of promoter constructs
contains the same promoter sequence amplified from H1 lineage
and various 59-UTRs from distinct DRB1 lineage, which were
denoted as P1-59U1, P1-59U2, P1-59U3 and P1-59U4, respective-
ly. In these two constructs, the fusion fragment of promoter
sequence and 59-UTR were inserted into the Hind III and Nco I
site, so they do not contain the 59-UTR of luciferase reporter gene
from the vector itself (Figure S5B). The third kind of promoter
vectors was constructed by inserting the PCR segments from
different DRB1 lineages containing with or without the 59-UTR
into the Kpn I and Sma I sites, which were designated as P1-59U1H,
P2-59U2H, P3-59U3H, P4-59U4H, P1-W, P2-W, P3-W and P4-
W, respectively. The former 4 vectors contain the 59-UTRs, and
the later 4 vectors are absent from the DRB1 derived 59-UTR.
(Figure S5C).
One LTR (MER11C) element is about 1.1 kb, which was
inserted into the promoter region of H3 and H4 lineages upstream
at the position 2938 to 22065. Here, we defined the position of
LTR elements as indel site, and use an ‘‘A’’ represent the distal
promoter that located upstream of the indel site, an ‘‘I’’ indicates
the LTR elements, a ‘‘C’’ denotes the proximal promoter that
located between translation start site and indel site, and H1-4
represent the 4 distinct promoter lineage. To investigate whether
the LTR element influences on the transcription activity of the
promoter, we constructed 4 constitutive promoter vectors
designated as H1AC, H2AC, H3AIC and H4AIC, respectively.
Simultaneously, we constructed four recombinant plasmids
namely H2AIC, IH2C, H3AC and IH3C, respectively (shown
on the left of Figure 5).
We amplified the fragment containing the complete 39-UTR
and about 300 bp long downstream sequence from the poly(A)
signal site from each 39-NCR lineage of HLA-DRB1, which is
about 586–594 bp long. We denoted the fragments of 39-UTR
from UTH1, UTH2, UTH3, UTH4 and UTHx as 39U1, 39U2,
39U3, 39U4 and 39Ux, respectively, and constructed them into
pGL3.0 Basic vector or pGL3.0 control vector between Xba Ia n d
BamH I site. We successfully constructed four different kinds of
vectors and confirmed its fidelity by sequencing. 1) The vector in
which the 39-UTR and 59-UTR of the luciferase gene were
simultaneously substituted for that from different DRB1 lineages
(Figure S6A). 2) The luciferase gene was placed under the control
of the promoter from H2 lineage and the 39-UTR from different
DRB1 lineages (Figure S6B). 3) The luciferase gene was placed
under the control of the long promoter and 39-UTR from the
same DRB1 lineage, and simultaneously created two recombi-
nant plasmids in which the luciferase gene was placed under the
control of the long promoter from H2 lineage (H2AC) and the 39-
UTR from UTH3 lineage (39U3), as well as from H3 lineage
(H3AIC) and the 39-UTR from UTH2 lineage (39U2).(Figure
S6C).
Transfection and luciferase assay
All plasmids for transfection were extracted with Qiagen Midi
Kit-25 (Valencia CA, USA) according to manufacturer’s instruc-
tion. The concentration of each construct was measured with
Spectrophotometer ND-1000. Burkitt’s lymphoma B cell line Raji
was propagated with RPMI 1640 culture medium supplemented
with 10% fetal bovine serum (FBS), 100 U/ml penicillin, and
100 mg/ml streptomycin. All promoter constructs and an internal
control (pRL-TK vector) were co-transfected into Raji cells by
electroporation, and into 293T cells with lipofactamine2000
(Invitrogen). The electroporation was performed as following: the
mix of 200–400 ml cells and plasmids were transferred into a 4 mm
cuvette pre-cooled on ice and discharged for 25 ms at 160 V on a
Genepulser Xcell (Bio-Rad). Then, the cells were transferred to
wells containing 2 ml RPMI 1640 complete culture medium and
incubated at 37uC in a CO2 incubator with moist ambient air for
36–48 hours. The procedure of transfection with lipofacta-
mine2000 was according to the manufacturer’s instruction.
Transfected cells were harvested and schizolysed with passive
lysis buffer attached with the Dual-Luciferase reporter assay
system (Promega). Then, the enzyme activity of the reporter gene
including the internal control was assayed with the Dual-
Luciferase reporter assay system on a chemoluminescence meter
(Monolight 3010C, Pharmingen). The fluorescence intensity
representing promoter activity of each lineage was normalized
by internal control and comparison was performed among all
lineages.
Data analysis
Sequence assembly was performed manually with BioEdit
version 7.0 and the sequence alignment was carried out with
clustalX 1.81. The polymorphism level, p (the average number of
pairwise nucleotide differences per site) and hw (the number of
segregating sites per nucleotide), was calculated with DnaSP
version 4.50.3 [55]. Phylogenetic trees were constructed by
MEGA3.1 [56] using the distance matrix calculated by Kimura’s
two-parameter method and the neighbor-joining method. The
reliability of the NJ trees was assessed by bootstrapping with 1,000
pseudosamples.
Data for analysis of promoter activity were expressed as the
mean 6 standard error of mean (s.e.m.) from at least 3 separate
experiments. Unless otherwise noted, the differences between
groups were analyzed using Student t test when only 2 groups, or
assessed by one-way ANOVA when more than 2 groups were
compared. All tests performed were two-sided. Differences were
considered statistically significant at P,0.05.
Supporting Information
Figure S1 Phylogenetic Analysis for the 39-UTR and 39-
UTR Downstream Sequences (39-UTR-DS). Taxon names
that designated with UTH plus numbers represent haplotypes
containing 39-UTR or 39-UTR downstream sequences. UTHx
signifies that the haplotype is distinct from the others. The arrow
indicated the different position of the UTHx haplotype on the 39-
UTR tree and 39-UTR-DS tree. The chimpanzee and rhesus
sequences were used as reference sequences. The haplotypes
belonging to the same lineage were denoted with opposite bracket.
(JPG)
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morphisms and Frequency Spectrum Analysis for the
Promoter Sequences of HLA-DRB1. A mutation of size i
means that is occurs i times in our sample of 52 sequences. The
thin line represents the expected frequency spectrum in neutral
equilibrium, and the black bars denote the observed values.
(JPG)
Figure S3 Polymorphism in the Core Promoter Region
of Partial DRB Alleles from human, chimpanzee, rhesus
and marmoset. The numbering is relative to the transcription
start site. The cis-element box was encircled with a pane and the
core sequence in a cis-element box was marked with underline.
(JPG)
Figure S4 The Sketch of the Relative Position of Primers
at HLA-DRB1 Gene. The number A–I represents the primers at
certain position, for example, B represents the 5 primers designated
as H1ASP1R, H21ASP1R,H22ASP1R,H3ASP1R and H4ASP1R
which are specific for different sequence lineage. The distance
marked in the figure denotes the approximate size of PCR product
which varying for different lineage.
(JPG)
Figure S5 The Sketch Map of Construction of HLA-
DRB1 Promoter Vectors. Only the reporter gene and its 59
flanking region in which the multiple clonal sites are located, were
shown on the sketch. The numbers in the parenthesis following the
names of restriction endonuclease (REN) denote the relative
positions of the RENs at the vector sequence. The rectangles below
multiclonal sites represent the fragments of promoters or 59UTRs
from HLA-DRB1 genes, which have been inserted into the REN
sites denoted by triangles. Three different kinds of promoter vectors
were constructed and shown on A, B and C, respectively.
(JPG)
Figure S6 The Sketch Map of Construction of HLA-
DRB1 39UTR and recombinant Vectors. Only the reporter
gene and its 59 flanking region in which the multiple clonal sites
are located were shown on the sketch. The numbers in the
parenthesis following the names of restriction endonuclease (REN)
denote the relative positions of the RENs at the vector sequence.
The rectangles below multiclonal sites represent the fragments of
promoters or 39UTRs from HLA-DRB1 genes, which have been
inserted into the REN sites denoted by triangles. Three different
kinds of vectors were constructed and shown on A, B and C,
respectively.
(JPG)
Table S1 Neutral test in DRB1 promoter region and 39
non-coding region with our data.
(XLS)
Table S2 All primer sequences involved in this paper.
(XLS)
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